- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Unresectable Malignant Solid Neoplasm in Canada
Total 602 results
-
National Cancer Institute (NCI)Active, not recruitingRefractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Ewing Sarcoma | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Refractory Ewing Sarcoma | Recurrent Alveolar Rhabdomyosarcoma | Refractory Alveolar RhabdomyosarcomaUnited States, Canada
-
Lawson Health Research InstituteRecruitingNon-small Cell Lung Cancer Stage IB (Resectable) | Non-small Cell Lung Cancer Stage II (Resectable) | Non-small Cell Lung Cancer Stage ⅢA (Resectable)Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | GanglioneuroblastomaUnited States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand
-
National Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Rhabdoid Tumor | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Rhabdoid Tumor | Refractory Rhabdoid Tumor | Epithelioid Sarcoma | Kidney Medullary Carcinoma | Atypical Teratoid/Rhabdoid Tumor | Poorly Differentiated Chordoma | Recurrent Atypical... and other conditionsUnited States, Australia, Canada
-
University of AlbertaCapital Health, CanadaCompletedMalignant Gliomas, Glioblastoma MultiformeCanada
-
Ontario Clinical Oncology Group (OCOG)Novartis PharmaceuticalsTerminatedAdvanced Malignant Pleural Mesothelioma | MPMCanada
-
National Cancer Institute (NCI)CompletedRefractory Malignant Solid Neoplasm | Recurrent Melanoma | Recurrent Malignant Solid Neoplasm | Recurrent Thyroid Gland Carcinoma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Thyroid Gland Medullary CarcinomaUnited States, Canada
-
Ottawa Hospital Research InstituteUnknownMalignant Pleural EffusionCanada
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChildhood Malignant NeoplasmUnited States, Canada, Australia, Puerto Rico, Switzerland
-
University of SaskatchewanCompleted
-
McGill University Health Centre/Research Institute...Unknown
-
YM BioSciencesCIMYM BioSciencesCompleted
-
University Health Network, TorontoActive, not recruiting
-
University Health Network, TorontoRecruitingCancer | Solid Tumor | Metastatic Cancer | Immune ResistanceCanada
-
Centre hospitalier de l'Université de Montréal...Centre de Recherche du Centre Hospitalier de l'Université de MontréalCompletedPancreatic Cancer | Unresectable Pancreatic CancerCanada
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChildhood Malignant NeoplasmUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Stephen CoubanGenzyme, a Sanofi CompanyCompletedMalignant Lymphoma, Stem Cell TypeCanada
-
AstraZenecaActive, not recruitingSolid TumorsUnited Kingdom, Canada
-
AstraZenecaCompletedAdvanced Solid TumorsDenmark, Canada
-
University Health Network, TorontoRecruiting
-
Children's Oncology GroupNational Cancer Institute (NCI); PfizerCompletedRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Childhood Anaplastic Large Cell LymphomaUnited States, Canada
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Daiichi Sankyo Co., Ltd.RecruitingSolid Tumor | Metastatic Solid Tumor | Advanced CancerJapan, United States, Canada
-
TakedaTakeda Development Center Americas, Inc.RecruitingUnresectable Locally Advanced or Metastatic CancerSpain, United States, Australia, Canada
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesFrance, Spain, Canada
-
AstraZenecaRecruitingUnresectable Pleural MesotheliomaDenmark, Italy, Australia, Korea, Republic of, Belgium, United States, Canada, Japan, United Kingdom, China, Brazil, France, Taiwan, Spain, Norway, Switzerland, Turkey, Poland, Germany, South Africa, Netherlands
-
NCIC Clinical Trials GroupNexstar PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Bristol-Myers SquibbTerminatedCancer | Neoplasm | Tumors | MalignancyUnited States, Canada, Spain, Switzerland
-
Hamilton Health Sciences CorporationOntario Clinical Oncology Group (OCOG); Juravinski Cancer Centre FoundationUnknownMetastatic Malignant Neoplasm to the Adult BrainCanada
-
NRG OncologyNational Cancer Institute (NCI)CompletedCognitive Impairment | Metastatic Malignant Neoplasm in the Brain | Solid NeoplasmUnited States, Canada
-
AO Foundation, AO SpineOrthopaedic Research FoundationCompletedSecondary Malignant Neoplasm of Vertebral ColumnUnited States, Canada, Hungary
-
AstraZenecaDaiichi SankyoNot yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerCanada
-
Neurogene Inc.Merck Sharp & Dohme LLCActive, not recruitingSolid Tumor | Advanced Solid TumorUnited States, Australia, Canada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsCanada, United States
-
University of British ColumbiaCompletedUnresectable Hepatocellular Carcinoma | Undergoing Chemoembolization and RadioembolizationCanada
-
University Health Network, TorontoCompletedPreviously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV MelanomaCanada
-
Bristol-Myers SquibbTerminatedAdvanced Solid MalignanciesUnited States, Canada
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingLocally Advanced or Metastatic Malignant Solid TumorsUnited States, Japan, Canada
-
Hoffmann-La RocheTerminatedSolid TumorsSpain, Belgium, Denmark, Canada
-
Merck Sharp & Dohme LLCCompletedSolid TumorsUnited States, Canada, Switzerland
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
NCIC Clinical Trials GroupCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
British Columbia Cancer AgencyBC Cancer Foundation; Pancreatic Cancer CanadaUnknownResectable Pancreatic Ductal AdenocarcinomaCanada
-
Gilead SciencesRecruitingSolid TumorsAustralia, United States, Canada
-
University Health Network, TorontoBayer; AstraZeneca; Amgen; AnHeart Therapeutics Inc.; Applied Health Research Centre and other collaboratorsRecruitingCancer | Malignancies Multiple | Malignant Solid Tumor | Cancer, Therapy-Related | Molecular Sequence Variation | Genetic Alteration | Gene Fusion | Receptor Tyrosine Kinase Gene Mutation | RTK Family Gene Mutation | Ras (Kras or Nras) Gene MutationCanada
-
Genentech, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid Tumors | Recurrent Solid TumorsAustralia, United States, Canada
-
Grupo Español Multidisciplinar de MelanomaGlaxoSmithKlineCompletedMalignant Melanoma Stage IV | Malignant Melanoma Stage IIIcSpain
-
Merck Sharp & Dohme LLCRecruitingNeoplasms | Advanced/Metastatic Solid TumorsCanada, Israel, United States, Netherlands
-
Regeneron PharmaceuticalsSanofiCompletedSolid TumorsUnited States, Canada